MAYNE PHARMA LTD ORDINARY (MYX) Short Interest
MAYNE PHARMA LTD ORDINARY (ASX:MYX) had 2.52% of shares reported as short positions as of 16 July 2026, representing 2,048,813 shares. MAYNE PHARMA LTD ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Mayne Pharma Group
Mayne Pharma Group Limited is a specialty pharmaceutical company listed on the ASX, focused on commercializing pharmaceuticals and improving patient access to life-enhancing medications. The company has a 40-year track record of innovation in developing oral drug delivery systems, offering a portfolio of branded and generic drugs in therapeutic areas like women's health and dermatology.
Short position
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4MYX intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Company
AI-generated research profile of Mayne Pharma Group
Latest MYX news
All news- Notification regarding unquoted securities - MYX
asx
- Mayne Pharma (ASX:MYX): Pharma Stock Gains as Healthcare Investors Watch Recovery Catalysts - Kalkine
googlenews
- Initial Director's Interest Notice
asx
- Mayne Pharma Group (ASX:MYX) Share Price Rises 3.89% as Healthcare Stocks Gain Momentum - Kalkine
googlenews
- Adveritas (ASX:AV1), Mayne Pharma (ASX:MYX): Penny Stocks to Watch
kalkine
About
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Be the first to discuss MYX
Start a research thread or post the first pulse update